CAS: 152923-56-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Daclizumab REF: TM-T73689CAS: 152923-56-3 | SDS-PAGE:95% SEC-HPLC:99.99% | 202.00 €~2,262.00 € | Mon 03 Mar 25 |
 | Daclizumab REF: 3D-CLA1061CAS: 152923-56-3 | - - - | 471.00 €~1,628.00 € | Tue 15 Apr 25 |
Daclizumab
CAS:152923-56-3
Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.
Purity:
SDS-PAGE:95% SEC-HPLC:99.99%
Color and Shape:
Liquid
Molecular weight:
144.12 kDa
Ref: TM-T73689
| 1mg | 202.00 € | ||
| 5mg | 512.00 € | ||
| 10mg | 820.00 € | ||
| 25mg | 1,225.00 € | ||
| 50mg | 1,673.00 € | ||
| 100mg | 2,262.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
Ref: 3D-CLA1061
| 1mg | 471.00 € | ||
| 5mg | 1,127.00 € | ||
| 10mg | 1,628.00 € |
Estimated delivery in United States, on Tuesday 15 Apr 2025
